Cargando…

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study

BACKGROUND: Human papillomavirus (HPV)-based screening programs still use one-size-fits-all protocols but efficiency and efficacy of programs may be improved by stratifying women based on previous screening results. METHODS AND FINDINGS: We studied the association between cervical intraepithelial ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inturrisi, Federica, Rozendaal, Lawrence, Veldhuijzen, Nienke J., Heideman, Daniëlle A. M., Meijer, Chris J. L. M., Berkhof, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616214/ https://www.ncbi.nlm.nih.gov/pubmed/36306283 http://dx.doi.org/10.1371/journal.pmed.1004115

Ejemplares similares

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test
por: Polman, Nicole J, et al.
Publicado: (2017)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
por: Bulk, S, et al.
Publicado: (2006)

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping
por: Dick, Stèfanie, et al.
Publicado: (2021)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV
por: Kremer, Wieke W., et al.
Publicado: (2018)

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
por: Inturrisi, Federica, et al.
Publicado: (2021)

HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
por: Gök, Murat, et al.
Publicado: (2010)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping
por: Hernández-López, Rubí, et al.
Publicado: (2019)

A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers()
por: Vasiljević, Nataša, et al.
Publicado: (2014)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

Searching HPV genome for methylation sites involved in molecular progression to cervical precancer
por: Kottaridi, Christine, et al.
Publicado: (2019)

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
por: Rijkaart, D C, et al.
Publicado: (2012)

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears
por: Zielinski, G D, et al.
Publicado: (2001)

Risk Factors for Cervical Precancer and Cancer in HIV-Infected, HPV-Positive Rwandan Women
por: Anastos, Kathryn, et al.
Publicado: (2010)

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency
por: Bulk, S, et al.
Publicado: (2007)

Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer
por: Safaeian, Mahboobeh, et al.
Publicado: (2012)

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases
por: Gök, M, et al.
Publicado: (2011)

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
por: Coupé, V M H, et al.
Publicado: (2008)

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
por: Luttmer, Roosmarijn, et al.
Publicado: (2016)

HPV-specific risk assessment of cervical cytological abnormalities
por: Zhong, Guanglei, et al.
Publicado: (2021)

Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: Experience from Battor, Ghana
por: Effah, Kofi, et al.
Publicado: (2023)

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
por: Arbyn, Marc, et al.
Publicado: (2018)

HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer
por: Arbyn, Marc, et al.
Publicado: (2022)

Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination
por: Song, Fangbin, et al.
Publicado: (2022)

Cervical precancer screening with HPV DNA testing and mobile colposcopy in women with sickle cell disease in Accra, Ghana
por: Dei-Adomakoh, Yvonne, et al.
Publicado: (2023)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

Extended duration of the detectable stage by adding HPV test in cervical cancer screening
por: van den Akker-van Marie, M E, et al.
Publicado: (2003)

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening
por: Verhoef, Lisanne, et al.
Publicado: (2023)

Cervical cytological abnormalities and HPV infection in perinatally HIV–infected adolescents
por: Ananworanich, J, et al.
Publicado: (2015)

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test
por: Rijkaart, D C, et al.
Publicado: (2010)

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
por: De Strooper, Lise M.A., et al.
Publicado: (2018)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology
por: Crawford, Robin, et al.
Publicado: (2011)

HPV Genotype Specific and Age Stratified Immediate Prevalence of Cervical Precancers and Cancers in Women with NILM/hrHPV+: A Single Center Retrospective Study of 26,228 Cases
por: Liu, Qin, et al.
Publicado: (2021)

Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening
por: Heideman, Daniëlle A. M., et al.
Publicado: (2022)

HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities
por: Krashias, George, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lddsfckimeiq1754dqsf0efivo